Cereno Scientific gets FDA clearance for phase IIb PAH trial
Go back to Cereno Scientific gets FDA clearance for phase IIb PAH trial| BARNES GROUP, Inc. (NYSE: B) | Delayed: 40.34 -0.95 (2.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.29 | 52 Week High | $44.27 | |||
| Open | $41.34 | 52 Week Low | $30.07 | |||
| Day High | $42.22 | P/E | 30.79 | |||
| Day Low | $39.72 | EPS | $1.31 | |||
| Volume | 16,398,756 | |||||
